A new study by Scripps Research reveals that alcohol dependence disrupts two signaling pathways in a stress-related part of the brain-and offers insights on developing drugs to treat this condition.

New therapies for multiple myeloma are dramatically improving prognosis and extending survival. Better disease control is prolonging remission and allowing patients to live without any sign of disease ...

BENTONVILLE, AR, UNITED STATES, December 3, 2025 /EINPresswire.com/ -- Empathy Health Technologies, the makers of the Sober Sidekick platform, today announced a $7.6 ...

Substance abuse treatment is a complex and multifaceted journey, and one of the most effective tools in this process is group therapy. Whether you or a loved one is seeking help, learning a few group ...

Over one-third of MS patients do not fully recover post-relapse, with severity as the strongest predictor of incomplete recovery. Relapse-associated worsening (RAW) is crucial in understanding ...

Relapse isn’t a failure. It’s a signal. It tells us that something deeper is still driving our old behaviors. For decades, I’ve studied the science of addiction, relapse, and behavior change through ...

Ublituximab shows five year relapse reduction and disability benefits in multiple sclerosis, supporting early high efficacy ...

Of 924 patients included, 148 (16%) patients relapsed during a median follow-up of 6.3 years. Invasion of the testicular hilum (rete testis and hilar soft tissue), lymphovascular invasion, and ...

Disability progression independent of relapse activity (PIRA) -- sometimes referred to as silent progression -- is a key integrating concept in the contemporary view of multiple sclerosis (MS). "The ...